[Our clinical experience with a new lytic mixture associated with rupture of the fetal membranes in labor; action of efocaine and dihydroergotamine].
D002317:Cardiovascular Agents; D004087:Dihydroergotamine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005321:Extraembryonic Membranes; D005260:Female; D006801:Humans; D007743:Labor, Obstetric; D010120:Oxytocics; D011247:Pregnancy; D011343:Procaine / Q000031:analogs & derivatives; D012421:Rupture
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D004087:Dihydroergotamine; D011343:Procaine
ERGOT ALKALOIDS/therapeutic use; FETAL MEMBRANES/rupture; LABOR; PROCAINE/related compounds
Nuestra experiencia clinica con una nueva mezcla litica asociada con la rotura de la bolsa en el parto; la accion de la efosina y dihidroergotamina.